198 related articles for article (PubMed ID: 32747326)
1. An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetine.
Amitai M; Taler M; Lebow M; Ben-Baruch R; Apter A; Fennig S; Weizman A; Chen A
Eur Neuropsychopharmacol; 2020 Nov; 40():61-69. PubMed ID: 32747326
[TBL] [Abstract][Full Text] [Related]
2. Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth.
Amitai M; Taler M; Ben-Baruch R; Lebow M; Rotkopf R; Apter A; Fennig S; Weizman A; Chen A
Brain Behav Immun; 2020 Jul; 87():301-308. PubMed ID: 31887416
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
4. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil to-lymphocyte and platelet-to-lymphocyte ratios as biomarkers for suicidal behavior in children and adolescents with depression or anxiety treated with selective serotonin reuptake inhibitors.
Amitai M; Kaffman S; Kroizer E; Lebow M; Magen I; Benaroya-Milshtein N; Fennig S; Weizman A; Apter A; Chen A
Brain Behav Immun; 2022 Aug; 104():31-38. PubMed ID: 35470013
[TBL] [Abstract][Full Text] [Related]
6. Suicidality in pediatric patients treated with antidepressant drugs.
Hammad TA; Laughren T; Racoosin J
Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
8. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
Morrison J; Schwartz TL
Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
[TBL] [Abstract][Full Text] [Related]
9. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
[TBL] [Abstract][Full Text] [Related]
10. Suicidality and self-injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing.
Sørensen JØ; Rasmussen A; Roesbjerg T; Verhulst FC; Pagsberg AK
Acta Psychiatr Scand; 2022 Feb; 145(2):209-222. PubMed ID: 34374070
[TBL] [Abstract][Full Text] [Related]
11. Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials.
Thase ME; Edwards J; Durgam S; Chen C; Chang CT; Mathews M; Gommoll CP
Int Clin Psychopharmacol; 2017 Sep; 32(5):281-288. PubMed ID: 28538024
[TBL] [Abstract][Full Text] [Related]
12. Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.
Tauscher-Wisniewski S; Disch D; Plewes J; Ball S; Beasley CM
Psychol Med; 2007 Nov; 37(11):1585-93. PubMed ID: 17640442
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.
Giner L; Nichols CM; Zalsman G; Oquendo MA
Int J Adolesc Med Health; 2005; 17(3):211-20. PubMed ID: 16231472
[TBL] [Abstract][Full Text] [Related]
14. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
15. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
KoKoAung E; Cavenett S; McArthur A; Aromataris E
JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
17. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
[TBL] [Abstract][Full Text] [Related]
18. Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents.
Sørensen JØ; Rasmussen A; Roesbjerg T; Pagsberg AK
Eur Child Adolesc Psychiatry; 2020 May; 29(5):707-718. PubMed ID: 31701374
[TBL] [Abstract][Full Text] [Related]
19. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
20. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
